News and research before you hear about it on CNBC and others. Request your one-week free trial of StreetInsider Premium here.
Dallas, Texas, June 14, 2021 (GLOBE NEWSWIRE) – Puration, Inc. (OTC Pink: PURA) today announced with Alkame Holdings, Inc. (OTC Pink: ALKM) PURA’s previously announced commitment to increase its investment in ALKM .
PURA took a five percent stake in ALKM in an earlier investment initiative.
PURA is working with ALKM and North American Cannabis Holdings, Inc. (OTC Pink: USMJ) on the development of a number of new CBD-infused products. The new investment by PURA is aimed at financing ALKM for the formulation of the products and the construction of the ALKM plant for the manufacture of the products. USMJ will manage the marketing of the new CBD-infused products.
The investment transaction is now complete. PURA has made advances available for ALKM in order to formulate products and to set up the ALKM factory for the manufacture of new products. While the investment, like all investments, is at risk, PURA expects that the investment will ultimately result in ALKM creating new products for PURA, with PURA’s return from selling the new products with no long-term impact on debt or equity ALKM is coming.
For more information about Puration, visit http://www.purationinc.com Contact: Puration, Inc. Brian Shibley, firstname.lastname@example.org +1 (800) 861-1350
Disclaimer / Safe Harbor: This press release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the company’s current beliefs about future events that involve risks and uncertainties. These risks include, but are not limited to, the expectation that Puration, Inc. will generate significant revenue, the failure to meet the deadline or performance requirements of the company’s contracts, the company’s liquidity position, the company’s ability to win new contracts, the emergence of competitors having greater financial resources and the effects of competitive prices. Given these uncertainties, the forward-looking events discussed in this press release may not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Source: Puration Inc.